Lombard Odier Asset Management (USA)’s Acadia Pharmaceuticals ACAD Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-75,000	Closed	-$2.44M	–	239
2016 Q2	$2.44M	Sell	75,000 -20,000	-21%	-$669K	0.29%	93
2016 Q1	$2.66M	Buy	+95,000	New	+$2.07M	0.36%	98
2015 Q2	–	Sell	-46,044	Closed	-$1.5M	–	191
2015 Q1	$1.5M	Buy	+46,044	New	+$1.58M	0.12%	140
2014 Q4	–	Sell	-225,000	Closed	-$5.57M	–	189
2014 Q3	$5.57M	Buy	225,000 +25,000	+13%	+$585K	0.38%	90
2014 Q2	$4.52M	Buy	200,000 +100,000	+100%	+$2.09M	0.24%	108
2014 Q1	$2.43M	Hold	100,000	–	–	0.09%	153
2013 Q4	$2.5M	Hold	100,000	–	–	0.11%	122
2013 Q3	$2.75M	Sell	100,000 -100,000	-50%	-$2.09M	0.14%	103
2013 Q2	$3.63M	Buy	+200,000	New	+$2.75M	0.2%	101

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s ACAD Position: Q3 2016 in Review

Lombard Odier Asset Management (USA) sold out of Acadia Pharmaceuticals (ACAD) in Q3 2016, closing a stake of 75,000 shares — an estimated $2.44M sold.

Lombard Odier Asset Management (USA) first reported a position in ACAD in Q2 2013 and held it in 9 quarters. The position peaked at $5.57M in Q3 2014. 233 funds tracked by Wall St. Rank hold ACAD as of Q3 2016.

Lombard Odier Asset Management (USA) reported no remaining Acadia Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 75,000 Acadia Pharmaceuticals shares in Q3 2016, an estimated $2.44M.
Lombard Odier Asset Management (USA) first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Lombard Odier Asset Management (USA)'s Acadia Pharmaceuticals position peaked at $5.57M in Q3 2014.
233 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2016, filed 15 Nov 2016.